Phase 2 Clinical Trial
The study lasted 8 weeks and included 5 visits to an ophthalmologist. Patients were provided with ophthalmic drops of Lacripep™ or placebo. Lacripep™ is a synthetic tear protein fragment of ‘lacritin’. Lacritin and a natural version of Lacripep™ are constituents of normal human tears but are lacking in dry eye tears. In preclinical studies, both […]
Our Solution – LacripepTM
The co-founder discovered ‘lacritin’, a natural tear protein selectively deficient in dry eye and yet when added topically to eyes of dry eye animals restores basal tearing without irritation and homeostasis of the eye surface. TearSolutions has developed a proprietary synthetic fragment of lacritin, Lacripep™. Lacripep™ is water soluble, stable in human tears, and equipotent […]
Dry Eye Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer quis diam et magna pretium convallis. Ut tempor tellus vitae tortor tincidunt viverra. Sed pharetra eget diam quis tincidunt. Aenean euismod semper nunc, eu consequat arcu pharetra in. Nulla facilisi. Vivamus congue felis massa, eu elementum nisl lacinia a. Nulla non enim eu mi bibendum mattis. […]